Targeting Myddosome Signaling in Waldenström’s Macroglobulinemia with the Interleukin-1 Receptor-associated Kinase 1/4 Inhibitor R191

PURPOSE: Waldenström’s macroglobulinemia is an incurable lymphoproliferative disorder driven by an L265P mutation in the Myeloid differentiation primary response gene 88 (MYD88), which activates downstream Nuclear factor kappa-B (NF-κB) signaling through the Myddosome. As this pathway depends in par...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Cancer Res
Asıl Yazarlar: Haiwen, Ni, Shirazi, Fazal, Baladandayuthapani, Veerabhadran, Lin, Heather, Kuiatse, Isere, Wang, Hua, Jones, Richard J., Berkova, Zuzana, Hitoshi, Yasumichi, Ansell, Stephen M., Treon, Steven P., Thomas, Sheeba K., Lee, Hans C., Wang, Zhiqiang, Davis, R. Eric, Orlowski, Robert Z.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2018
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6295253/
https://ncbi.nlm.nih.gov/pubmed/30126942
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-17-3265
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller